Iom Bioworks Raises ₹4 Cr to Scale Gut Health Tech
In a significant development in the Indian startup ecosystem, Bengaluru-based Iom Bioworks has secured ₹4 crore in seed funding led by Inflection Point Ventures to scale its innovative gut microbiome healthcare platform. This fresh infusion of funds will be utilized to accelerate research and development, protect intellectual property, enhance marketing efforts, and expand the team. With its cutting-edge technology driven by artificial intelligence (AI) and at-home gut tests, Iom Bioworks aims to revolutionize preventive wellness in India through personalized dietary and microbiome interventions.
The gut microbiome, comprising trillions of microorganisms, plays a vital role in human health, influencing everything from digestion and immunity to mental wellbeing and overall disease susceptibility. However, the complexities of the gut microbiome have made it challenging for individuals to understand and manage their unique gut health profiles. Iom Bioworks seeks to bridge this knowledge gap by providing personalized solutions tailored to an individual’s unique gut microbiome.
The startup’s flagship platform utilizes AI-driven insights to analyze data from at-home gut tests, offering a comprehensive understanding of an individual’s gut health. This information is then used to create personalized dietary and microbiome interventions, empowering individuals to take proactive steps towards maintaining optimal gut health. By addressing the root causes of various health issues, Iom Bioworks aims to reduce the risk of chronic diseases and improve overall wellbeing.
“We are thrilled to partner with Inflection Point Ventures, a visionary investor that shares our passion for revolutionizing preventive wellness,” said [Founder’s Name], CEO of Iom Bioworks. “This funding will enable us to accelerate our efforts in developing cutting-edge technology, expanding our team, and marketing our platform to a wider audience. We believe that our personalized gut microbiome healthcare platform has the potential to transform the way people approach their health and wellbeing.”
Inflection Point Ventures, a leading early-stage venture capital firm, is committed to supporting innovative startups that are poised to disrupt traditional industries. The firm’s investment in Iom Bioworks is a testament to the startup’s potential to create a significant impact in the healthcare sector.
“The gut microbiome is a rapidly evolving area of research, and Iom Bioworks is at the forefront of developing solutions that can improve human health,” said [Investor’s Name], Partner at Inflection Point Ventures. “We are impressed by the startup’s cutting-edge technology, entrepreneurial spirit, and commitment to making a positive impact. We believe that Iom Bioworks has the potential to create a new paradigm in preventive wellness and are excited to support their growth journey.”
The funding will enable Iom Bioworks to further strengthen its R&D capabilities, develop new products and services, and expand its team to support business growth. The startup plans to utilize the funds to:
- Enhance its AI-driven insights and analytics capabilities to provide more accurate and personalized recommendations.
- Develop new products and services focused on specific health conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).
- Expand its marketing efforts to reach a wider audience, including healthcare professionals, wellness enthusiasts, and individuals concerned about their gut health.
- Strengthen its research collaborations with leading institutions and experts in the field of microbiome research.
As Iom Bioworks scales its operations, it is poised to make a significant impact in the Indian healthcare landscape. The startup’s innovative approach to gut health and wellness has the potential to revolutionize the way people approach their health, empowering individuals to take proactive steps towards maintaining optimal wellbeing.
Source: https://ascendants.in/business-stories/iom-bioworks-gut-health-funding-2025/
